Distinct immunologic properties of Penicillium marneffei yeasts obtained from different in vitro growth conditions

Asian Pacific Journal of Allergy and Immunology

Volumn 22, Issue 4, 2004, Pages 229-235

  Tongchusak, Songsak ^a   Pongtanalert, Piyapong ^a   Pongsunk, Supinya ^a   Chawengkirttikul, Runglawan ^a   Chaiyaroj, Sansanee C ^a  

^a Mahidol University   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; GLUCOSE; PEPTONE; POLYCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; CONIDIUM; CONTROLLED STUDY; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS IMMUNITY; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; MACROPHAGE ACTIVATION; MYCOSIS; NONHUMAN; PENICILLIUM MARNEFFEI; PHAGOCYTOSIS; STRAIN DIFFERENCE; WESTERN BLOTTING; YEAST CELL;

ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD86; BLOTTING, WESTERN; CULTURE MEDIA; GENE EXPRESSION REGULATION, FUNGAL; MEMBRANE GLYCOPROTEINS; PENICILLIUM; PHAGOCYTOSIS; YEASTS;

EID: 14844359966     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Deng Z, Ribas JL, Gibson DW, Conner DH. Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis 1998; 10: 640-52.
2. Li JS, Pan LO, Wu SX, Su SX, Su SB, Shan LL. Disseminated penicilliosis marneffei in China. Report of three cases. Chin Med J 1991; 104: 247-51.
3. Supparatpinyo K, Kwamwan C, Baosoung V, Nelson KE, Sirisanthana, T. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 1994; 344: 10-3.
4. Tsang DN, Li PC, Tsui MS, Lau YT, Ma KF, Yeah EK. Penicillium marneffei: Another pathogen to consider in patients infected with human immunodeficiency virus. Rev Infect Dis 1991; 13: 766-7.
5. Ajello L, Padhye AA, Sukroongreung S, Nilakul CH, Tantimavanich S. Occurrence of Penicillium marneffei infections among wild bamboo rats in Thailand. Mycopathologia 1995; 131: 1-8.
6. Garrison RG, Boyd KS. Dimorphism of Penicillium marneffei as observed by electron microscopy. Can J Microbiol 1973; 19: 1305-9.
7. Chan YF, Chow TC. Ultrastructural observation on Penicillium marneffei in natural human infection. Ultrastruct Pathol 1990; 14: 439-52.
8. Andrianopoulos A. Control of morphogenesis in the human fungal pathogen Penicillium marneffei. Int J Med Microbiol 2002; 292: 1-18.
9. Sekhon AS, Garg AK, Pakye AA, Hamir Z. In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole. Eur J Epidemiol 1993; 9: 553-8.
10. Trewatcharegon S, Sirisinha S, Romsai A, Eampokalap B, Teanpaisan R, Chaiyaroj SC. Molecular typing of Penicillium marneffei isolates from Thailand by NotI macrorestriction pulsed-field gel electrophoresis. J Clin Microbiol 2001; 39: 4544-8.
11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
12. Trewatcharegon S, Chaiyaroj SC, Chongtrakool P, Sirisinha S. Production and characterization of monoclonal antibodies reactive with the mycelial and yeast phases of Penicillium marneffei. Med Mycol 2003; 38: 91-6.
13. Chan YF, Chow TC. Ultrastructural observations on Penicillium marneffei in natural human infection. Ultrastruct Pathol 1990; 14: 439-52.
14. Cogliati M, Roverselli A, Boelaert JR, Taramelli D, Lombardi L, Viviani MA. Development of an in vitro macrophage system to assess Penicillium marneffei growth and susceptibility to nitric oxide. Infect Immun 1997; 65: 279-84.
15. Jeavons L, Hamilton AJ, Vanittanakom N, Ungpakorn R, Evans EGV, Sirisanthana T, Hay RJ. Identification and purification of specific Penicillium marneffei antigens and their recognition by human immune sera. J Clin Microbiol 1998; 36: 949-54.
16. Kudeken N, Kawakami K, Saito A. Different susceptibility of yeasts and conidia of Penicillium marneffei to nitric oxide (NO)-mediated fungicidal activity of murine macrophage. Clin Exp Immunol 1998; 112:287-93.
17. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993; 90: 6586-90.
18. Vecchiarelli A, Monari C, Retini C, Pietrellia D, Palazzetti B, Pitzurra L, Casadevall A. Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes. Eur J Immunol 1998; 28: 114-21.
19. Difco Manual. 11th Edition. Difco Laboratories, Division of Becton Dickinson and Company. Sparks, Maryland, USA, 1998.
20. Attal HC, Grover S, Barisal MP, Chaubey BS, Joglekar UK. Capsule deficient Cryptococcus neoformans and unusual clinical presentation. J Assoc Physicians India 1983; 96: 383-7.
21. Kagaya K, Yamada T, Miyakawa Y, Fukazawa Y, Saito S. Characterization of pathogenic constituents of Cryptococcus neoformans strains. Microbiol Immunol 1985; 29: 517-32.